Search





Search





Markets
/
Stocks
/
vera
/

Vera Therapeutics Inc

VERA

Add to Watchlist

32.100USD

-0.950-2.87%

Close 07-31 16:00（ET）Quotes delayed by 15 min

2.30BMarket Cap

LossP/E TTM

Vera Therapeutics Inc

32.100

-0.950-2.87%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

VERA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Vera Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-95.75%-106.50M

-78.64%-69.99M

-67.84%-61.91M

-121.12%-54.80M

-60.82%-54.41M

-55.83%-39.18M

-60.56%-36.88M

-39.44%-24.78M

-28.67%-33.83M

-18.82%-25.14M

-24.72%-22.97M

6.63%-17.77M

-192.75%-26.29M

-228.70%-21.16M

-235.89%-18.42M

-148.31%-19.03M

-117.93%-8.98M

76.49%-6.44M

-124.11%-5.48M

-186.54%-7.67M

-78.79%-4.12M

---27.38M

---2.45M

---2.67M

---2.31M

Net income from continuing operations

-134.13%-121.03M

-109.78%-91.10M

-72.18%-80.29M

-127.04%-76.53M

-82.13%-51.69M

-69.27%-43.42M

-131.95%-46.63M

-67.19%-33.71M

5.61%-28.38M

20.91%-25.66M

18.54%-20.10M

-35.74%-20.16M

-76.00%-30.07M

-92.55%-32.44M

-224.25%-24.68M

-332.15%-14.85M

-262.43%-17.09M

60.71%-16.85M

-70.65%-7.61M

4.63%-3.44M

-90.54%-4.71M

---42.88M

---4.46M

---3.60M

---2.47M

Operating gains losses

64.71%140.00K

145.45%135.00K

437.50%129.00K

357.69%119.00K

--85.00K

--55.00K

--24.00K

--26.00K

----

-74.29%9.00K

-87.25%32.00K

-96.82%59.00K

-55.36%50.00K

-67.59%35.00K

--251.00K

--1.86M

--112.00K

--108.00K

Other non-cash items

1451.95%14.91M

72.41%-359.00K

89.99%-173.00K

41.43%-1.24M

-15.86%-1.10M

-104.88%-1.30M

-93.51%-1.73M

-420.15%-2.12M

-1404.11%-952.00K

-794.37%-635.00K

-121.94%-893.00K

-191.46%-407.00K

-87.06%73.00K

-101.46%-71.00K

3356.00%4.07M

378.13%445.00K

195.59%564.00K

-66.94%4.88M

-562.96%-125.00K

-633.33%-160.00K

-900.00%-590.00K

--14.75M

--27.00K

--30.00K

---59.00K

Change in working capital

-45.45%-13.73M

1523.35%10.36M

48.15%8.69M

117.81%13.38M

-9.50%-9.44M

64.95%-728.00K

219.31%5.86M

7044.19%6.14M

-931.95%-8.62M

-124.33%-2.08M

-956.77%-4.91M

101.20%86.00K

-82.35%1.04M

98.88%8.54M

-151.90%-465.00K

-197.11%-7.19M

688.84%5.87M

8315.69%4.29M

358.21%896.00K

-694.84%-2.42M

6100.00%744.00K

--51.00K

---347.00K

--407.00K

--12.00K

-Change in prepaid expenses

12.47%-5.14M

-175.00%-372.00K

132.88%606.00K

-36.99%1.71M

-1398.98%-5.88M

-38.69%496.00K

11.69%-1.84M

218.36%2.72M

-110.46%-392.00K

267.84%809.00K

-1255.19%-2.09M

36.24%-2.30M

195.10%3.75M

-168.27%-482.00K

-124.37%-154.00K

-2.47%-3.60M

-3003.94%-3.94M

647.29%706.00K

345.07%632.00K

-9669.44%-3.52M

-13.39%-127.00K

---129.00K

--142.00K

---36.00K

---112.00K

-Change in other current assets

-100.00%0.00

-88.89%1.00K

-133.75%-108.00K

984.62%141.00K

88.89%17.00K

1000.00%9.00K

8100.00%320.00K

104.35%13.00K

280.00%9.00K

92.31%-1.00K

93.94%-4.00K

1.32%-299.00K

-101.85%-5.00K

74.51%-13.00K

---66.00K

---303.00K

--271.00K

-186.44%-51.00K

----

--59.00K

----

-Change in other current liabilities

----

100.00%0.00

-100.00%0.00

---295.00K

---191.00K

--1.00K

--7.00K

Cash from non-recurring investing activities

Cash from operating activities

-95.75%-106.50M

-78.64%-69.99M

-67.84%-61.91M

-121.12%-54.80M

-60.82%-54.41M

-55.83%-39.18M

-60.56%-36.88M

-39.44%-24.78M

-28.67%-33.83M

-18.82%-25.14M

-24.72%-22.97M

6.63%-17.77M

-192.75%-26.29M

-228.70%-21.16M

-235.89%-18.42M

-148.31%-19.03M

-117.93%-8.98M

76.49%-6.44M

-124.11%-5.48M

-186.54%-7.67M

-78.79%-4.12M

---27.38M

---2.45M

---2.67M

---2.31M

Investing cash flow

Net cash from continuing investing activities

-7.49%173.00K

-84.19%102.00K

-44.12%133.00K

133.71%208.00K

--187.00K

923.81%645.00K

--238.00K

--89.00K

----

--63.00K

-100.00%0.00

--38.00K

100.75%6.00K

--18.00K

8871.93%5.00M

--0.00

-1793.62%-796.00K

-100.00%0.00

---57.00K

--0.00

--47.00K

--52.00K

Capital expenditures

-7.49%173.00K

-84.19%102.00K

-44.12%133.00K

133.71%208.00K

--187.00K

923.81%645.00K

--238.00K

--89.00K

----

--63.00K

-100.00%0.00

--38.00K

--6.00K

--18.00K

--5.00M

--0.00

-100.00%0.00

--0.00

--47.00K

--52.00K

Net cash flow from disposal of fixed assets

-7.49%173.00K

-84.19%102.00K

-44.12%133.00K

133.71%208.00K

--187.00K

923.81%645.00K

--238.00K

--89.00K

----

--63.00K

-100.00%0.00

--38.00K

100.75%6.00K

--18.00K

8871.93%5.00M

--0.00

-1793.62%-796.00K

-100.00%0.00

---57.00K

--0.00

--47.00K

--52.00K

Net cash flow from investment products

-854.54%-122.64M

136.59%80.77M

81.28%69.89M

227.51%28.80M

107.41%16.25M

-1285.55%-220.74M

137.58%38.55M

73.87%-22.59M

-1892.43%-219.29M

38.57%18.62M

775.60%16.23M

-105.40%-86.45M

131.02%12.23M

--13.44M

---2.40M

---42.09M

---39.44M

----

Net cash flow from other investing activities

-1900.00%-15.00M

--0.00

---50.00K

---750.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-999.76%-137.82M

136.44%80.66M

82.06%69.76M

225.87%28.54M

106.98%15.32M

-1293.05%-221.38M

136.12%38.32M

73.77%-22.68M

-1892.43%-219.29M

38.10%18.56M

765.08%16.23M

-105.37%-86.45M

131.01%12.23M

368.74%13.44M

---2.44M

-5388.19%-42.09M

---39.45M

-8871.93%-5.00M

--0.00

1793.62%796.00K

100.00%0.00

--57.00K

--0.00

---47.00K

---52.00K

Financing cash flow

Cash flow from continuous financing activities

157.14%3.94M

-12.17%286.28M

7.85%797.00K

489.85%20.29M

-99.45%1.53M

1212.85%325.95M

148.82%739.00K

696.06%3.44M

156.09%276.54M

19.89%24.83M

-67.29%297.00K

800.00%432.00K

34.53%107.98M

320.83%20.71M

--908.00K

-99.90%48.00K

286771.43%80.27M

-93.83%4.92M

100.00%0.00

7852.76%48.99M

-100.56%-28.00K

--79.80M

---94.00K

--616.00K

--4.97M

Net cash flow from debt Issuance/repayment

----

--0.00

--23.34M

----

24.85%24.74M

----

302.68%19.82M

----

100.00%0.00

27438.89%4.92M

100.00%0.00

103.13%1.00K

97.92%-1.00K

---18.00K

---32.00K

---48.00K

Net cash flow from common stock issuance/repurchase

----

-12.90%300.50M

100.00%0.00

--0.00

-100.00%0.00

--345.00M

---13.00K

--0.00

150.03%287.54M

--0.00

-100.00%0.00

33.52%115.00M

----

--2.00K

--1.00K

--86.13M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

-100.00%0.00

--0.00

--51.18M

----

--80.00M

----

Proceeds from stock option exercised by employees

157.14%3.94M

81.18%4.19M

5.98%797.00K

-86.51%464.00K

-77.82%1.53M

2556.32%2.31M

153.20%752.00K

696.06%3.44M

2779.58%6.91M

-89.48%87.00K

-69.54%297.00K

819.15%432.00K

2.56%240.00K

--827.00K

--975.00K

-77.40%47.00K

-31.58%234.00K

-100.00%0.00

100.00%0.00

201.45%208.00K

2180.00%342.00K

--207.00K

---61.00K

--69.00K

--15.00K

Net cash flow from other financing activities

--0.00

13.82%-18.41M

--0.00

---3.52M

100.00%0.00

---21.36M

--0.00

-146.80%-17.91M

-100.00%0.00

100.00%0.00

--0.00

-19.03%-7.26M

--66.00K

---69.00K

100.00%0.00

-1552.03%-6.10M

100.00%0.00

-10317.39%-2.40M

---369.00K

---388.00K

---1.00K

---23.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

157.14%3.94M

-12.17%286.28M

7.85%797.00K

489.85%20.29M

-99.45%1.53M

1212.85%325.95M

148.82%739.00K

696.06%3.44M

156.09%276.54M

19.89%24.83M

-67.29%297.00K

800.00%432.00K

34.53%107.98M

320.83%20.71M

--908.00K

-99.90%48.00K

286771.43%80.27M

-93.83%4.92M

100.00%0.00

7852.76%48.99M

-100.56%-28.00K

--79.80M

---94.00K

--616.00K

--4.97M

Net cash flow

Beginning cash balance

282.88%354.73M

111.96%57.77M

95.82%49.12M

-20.28%55.09M

102.81%92.65M

-0.67%27.26M

-25.98%25.09M

-49.81%69.11M

4.41%45.68M

-10.81%27.44M

-33.18%33.89M

23.15%137.68M

-45.29%43.75M

-64.42%30.77M

-44.85%50.72M

124.28%111.80M

48.10%79.97M

5586.00%86.48M

2164.11%91.97M

708.17%49.85M

1417.62%54.00M

--1.52M

--4.06M

--6.17M

--3.56M

Current period cash flow changes

-540.04%-240.37M

354.12%296.95M

298.53%8.65M

86.44%-5.97M

-260.33%-37.56M

258.50%65.39M

133.67%2.17M

57.59%-44.02M

-75.06%23.42M

40.48%18.24M

67.68%-6.45M

-69.93%-103.79M

195.07%93.93M

299.23%12.98M

-263.82%-19.95M

-245.01%-61.08M

867.22%31.83M

-112.42%-6.52M

-115.82%-5.48M

2100.00%42.12M

-258.97%-4.15M

--52.48M

---2.54M

---2.11M

--2.61M

Ending cash balance

107.57%114.35M

282.88%354.73M

111.96%57.77M

95.82%49.12M

-20.28%55.09M

102.81%92.65M

-0.67%27.26M

-25.98%25.09M

-49.81%69.11M

4.41%45.68M

-10.81%27.44M

-33.18%33.89M

23.15%137.68M

-45.29%43.75M

-64.42%30.77M

-44.85%50.72M

124.28%111.80M

48.10%79.97M

5586.00%86.48M

2164.11%91.97M

708.17%49.85M

--54.00M

--1.52M

--4.06M

--6.17M

Free cash flow

-95.40%-106.67M

-76.00%-70.10M

-67.12%-62.04M

-121.17%-55.01M

-61.37%-54.59M

-58.00%-39.83M

-61.59%-37.12M

-39.94%-24.87M

-28.67%-33.83M

-19.11%-25.21M

-24.46%-22.97M

6.65%-17.77M

-192.17%-26.29M

-85.01%-21.16M

-236.58%-18.46M

-148.39%-19.04M

-118.37%-9.00M

58.23%-11.44M

-124.11%-5.48M

-181.59%-7.67M

-74.84%-4.12M

---27.38M

---2.45M

---2.72M

---2.36M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Vera Therapeutics Inc Generate?



Vera Therapeutics Inc generated -241.10M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Vera Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Vera Therapeutics Inc's operating cash flow increased by -79.02% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Vera Therapeutics Inc Spend on Capital Expenditures?



Vera Therapeutics Inc spent 630.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Vera Therapeutics Inc's Financing Cash Flow Changed?



Vera Therapeutics Inc used 308.90M in financing activities in the latest quarter.

What is free cash flow and why does it matter for VERA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Vera Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -241.73M reflecting a -78.20% change from the previous year.